These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 6608972

  • 21. Central nervous effects of CRF and angiotensin II on cardiac output in conscious rats.
    Overton JM, Davis-Gorman G, Fisher LA.
    J Appl Physiol (1985); 1990 Aug; 69(2):788-91. PubMed ID: 2228889
    [Abstract] [Full Text] [Related]

  • 22. Corticotropin-releasing factor, sauvagine, and urotensin I: effects on blood flow.
    Lenz HJ, Fisher LA, Vale WW, Brown MR.
    Am J Physiol; 1985 Jul; 249(1 Pt 2):R85-90. PubMed ID: 3874558
    [Abstract] [Full Text] [Related]

  • 23. Evaluation for roles of periventricular cholinoceptors in vasopressin secretion in response to angiotensin II and an osmotic stimulus.
    Yamaguchi K, Hama H.
    Brain Res; 1989 Sep 04; 496(1-2):345-50. PubMed ID: 2804646
    [Abstract] [Full Text] [Related]

  • 24. Difference between intracarotid and intravenous infusions of angiotensin II on baroreflex sensitivity and vasopressin release in conscious rats.
    Fenoy FJ, Ubeda M, García-Estañ J, Quesada T.
    Rev Esp Fisiol; 1987 Sep 04; 43(3):355-60. PubMed ID: 3423394
    [Abstract] [Full Text] [Related]

  • 25. Atrial natriuretic polypeptide attenuates central angiotensin II-induced catecholamine and ACTH secretion.
    Makino S, Hashimoto K, Ota Z.
    Brain Res; 1989 Oct 30; 501(1):84-9. PubMed ID: 2553215
    [Abstract] [Full Text] [Related]

  • 26. Cardiovascular actions of the stress-related neurohormonal peptides, corticotropin-releasing factor and urotensin-I in the trout Oncorhynchus mykiss.
    Le Mével JC, Mimassi N, Lancien F, Mabin D, Conlon JM.
    Gen Comp Endocrinol; 2006 Mar 30; 146(1):56-61. PubMed ID: 16386738
    [Abstract] [Full Text] [Related]

  • 27. Effects of CRF and ANG II on ACTH and vasopressin release in conscious dogs.
    Klingbeil CK, Keil LC, Chang D, Reid IA.
    Am J Physiol; 1988 Jul 30; 255(1 Pt 1):E46-53. PubMed ID: 2839038
    [Abstract] [Full Text] [Related]

  • 28. Effects of corticotropin-releasing factor on central respiratory activity.
    Böhmer G, Schmid K, Ramsbott M.
    Eur J Pharmacol; 1990 Jul 17; 182(3):405-11. PubMed ID: 2226617
    [Abstract] [Full Text] [Related]

  • 29. Corticotropin-releasing factor receptor antagonist: effects on the autonomic nervous system and cardiovascular function.
    Brown MR, Gray TS, Fisher LA.
    Regul Pept; 1986 Dec 30; 16(3-4):321-9. PubMed ID: 3031745
    [Abstract] [Full Text] [Related]

  • 30. Plasma cortisol and catecholamine responses to intracerebroventricular administration of CRF to rhesus monkeys.
    Insel TR, Aloi JA, Goldstein D, Wood JH, Jimerson DC.
    Life Sci; 1984 May 07; 34(19):1873-8. PubMed ID: 6610811
    [Abstract] [Full Text] [Related]

  • 31. [Effects of ketanserin on hemodynamic changes after intracerebroventricular corticotropin releasing factor administration in rats].
    Satoh K, Kushiro T, Kajiwara N.
    Nihon Naibunpi Gakkai Zasshi; 1988 Apr 20; 64(4):303-9. PubMed ID: 3261263
    [Abstract] [Full Text] [Related]

  • 32. Cardiovascular and dipsogenic effects of angiotensin II administered i.c.v. in Long-Evans and Brattleboro rats.
    Harland D, Gardiner SM, Bennett T.
    Brain Res; 1988 Jul 05; 455(1):58-64. PubMed ID: 3416193
    [Abstract] [Full Text] [Related]

  • 33. Differential antagonist activity of alpha-helical corticotropin-releasing factor9-41 in three bioassay systems.
    Fisher L, Rivier C, Rivier J, Brown M.
    Endocrinology; 1991 Sep 05; 129(3):1312-6. PubMed ID: 1651845
    [Abstract] [Full Text] [Related]

  • 34. Somatostatin-28 effects on central nervous system regulation of vasopressin secretion and blood pressure.
    Brown MR.
    Neuroendocrinology; 1988 Jun 05; 47(6):556-62. PubMed ID: 2899849
    [Abstract] [Full Text] [Related]

  • 35. Corticotropin-releasing factor. Mechanisms to inhibit gastric acid secretion in conscious dogs.
    Lenz HJ, Hester SE, Brown MR.
    J Clin Invest; 1985 Mar 05; 75(3):889-95. PubMed ID: 3872315
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cardiovascular effects of long-term central and peripheral administration of urocortin, corticotropin-releasing factor, and adrenocorticotropin in sheep.
    Weisinger RS, Blair-West JR, Burns P, Denton DA, Purcell B, Vale W, Rivier J, Weisinger HS, May CN.
    Endocrinology; 2004 Dec 05; 145(12):5598-604. PubMed ID: 15319360
    [Abstract] [Full Text] [Related]

  • 38. Development of adrenergic and nonadrenergic pressor mechanisms in rats sympathectomized from birth.
    Mills E, Bruckert JW, Smith PG.
    J Pharmacol Exp Ther; 1986 Sep 05; 238(3):1014-20. PubMed ID: 3746656
    [Abstract] [Full Text] [Related]

  • 39. Central nervous system effects of corticotropin-releasing factor on gastrointestinal transit in the rat.
    Lenz HJ, Burlage M, Raedler A, Greten H.
    Gastroenterology; 1988 Mar 05; 94(3):598-602. PubMed ID: 3257450
    [Abstract] [Full Text] [Related]

  • 40. Mechanisms underlying the cardiovascular responses to intrathecal vasopressin administration in rats.
    Riphagen CL, Pittman QJ.
    Can J Physiol Pharmacol; 1989 Apr 05; 67(4):269-75. PubMed ID: 2758369
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.